Standard disease frameworks are meeting their ma
Browsing: All news
Category Added in a WPeMatico Campaign
Five-year renewal backs new drug discovery proje
A fresh analyst upgrade and encouraging clinical
Haut.
Alterity Therapeutics received official End-of-Ph
Catalent and Nanoscope Therapeutics expanded thei
RoslinCT and BlueRock Therapeutics have entered a
Aptorum Group Limited and DiamiR Biosciences anno
The seventh Longevity Investors Conference bring
Year-long study shows people with mild Alzheimer